© 2010 American Public Health Association DOI: 10.2105/AJPH.2008.147629
C. Kent Martin is with Medcenter One Health Systems, Bismarck, ND. Jeffrey E. Hostetter and John J. Hagan are with the North Dakota Department of Corrections and Rehabilitation, Bismarck, and the School of Medicine and Health Sciences, University of North Dakota, Bismarck. Correspondence: Correspondence should be sent to C. Kent Martin, MD, Medcenter One, 222 N 7th St, Bismark, ND 58501 (e-mail: kentmartin{at}bis.midco.net). Reprints can be ordered at http://www.ajph.org by clicking on the "Reprints/Eprints" link.
Hepatitis C in prison populations is now a major public health problem, and large numbers of correctional facilities have no comprehensive management program, often because of formidable projected costs and tightening budget constraints. The North Dakota Department of Corrections and Rehabilitation has operated a management and therapy program since 2002 using consensus interferon and ribavirin with 45% cost savings. The program has provided excellent sustained viral responses: 54.2% for genotype 1 hepatitis C, 75% for genotypes 2 and 3, and 63.6% overall.
| |||||||||||||||||||||